FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 09:26:10 06/06/2024 BST | ||
| 2.4 EUR | +2.56% |
|
| Current month | +15.44% | ||
| 1 month | -27.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 2.4 | +2.56% |
| 05/06/24 | 2.34 | 0.00% |
| 04/06/24 | 2.34 | +6.85% |
| 03/06/24 | 2.19 | +8.04% |
| 31/05/24 | 2.027 | +3.84% |
Real-time BOERSE MUENCHEN
Last update June 06, 2024 at 09:26 am
More quotesStatic data
| Product type | Productos Exóticos |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GZ8NQH |
| ISIN | DE000GZ8NQH9 |
| Date issued | 14/02/2023 |
| Strike | 276.6 $ |
| Maturity | Unlimited |
| Parity | 12.85 : 1 |
| Emission price | 8.75 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.46 € |
|---|---|
| Lowest since issue | 0.9 € |
| Spread | 0.05 € |
| Spread % | 2.05% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
307.4
USD
Average target price
316.3
USD
Spread / Average Target
+2.89%
- Stock Market
- Certificates
- Certificat
